Ting Xie (谢厅), PhD, CFA
Dr. Ting Xie is from Hillhouse BioVenture, which focuses on the investment of cutting-edge life science technologies and new therapies globally. Dr. Xie serves as a Board Member at various biotech companies. Prior to Hillhouse Capital he worked for a healthcare specialized private equity fund HealthCare Royalty Partners (HCR) in New York metro area and a Wall Street financial institution Alliance Bernstein covering biotech and specialty pharma. He obtained a PhD degree in Chemistry and Chemical Biology, Biological Chemistry and Molecular Pharmacology from Harvard University, and Bachelor of Science degree from Tsinghua University.